Hematopoietic fitness of JAK2V617F myeloproliferative neoplasms is linked to clinical outcome
Blood Adv
.
2022 Sep 27;6(18):5477-5481.
doi: 10.1182/bloodadvances.2022007128.
Authors
Ghaith Abu-Zeinah
,
Silvana Di Giandomenico
,
Daniel Choi
,
Tatiana Cruz
,
Katie Erdos
,
Elwood Taylor
,
Ellen K Ritchie
,
Richard T Silver
,
Joseph M Scandura
PMID:
35789232
PMCID:
PMC9631704
DOI:
10.1182/bloodadvances.2022007128
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Janus Kinase 2 / genetics
Myeloproliferative Disorders* / genetics
Neoplasms*
Substances
Janus Kinase 2
Grants and funding
UL1 TR002384/TR/NCATS NIH HHS/United States